Autologous Serum Eye Drops in Dry Eye Syndrome

Recruiting now · Not applicable

Conditions studied: Autologous Serum Eye Drops, Dry Eye Syndrome

In brief

This study aims to evaluate the clinical efficacy and safety of autologous serum eye drops (ASEDs) in patients with moderate-to-severe dry eye syndrome who are refractory to conventional artificial tear therapy.

Key facts

Study ID

NCT07295691

Run by

The General Authority for Teaching Hospitals and Institutes

People needed

70

Starts

2025-09-01

Expected to finish

2025-12-31

Last updated by the study team

2025-12-22

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children aged less than 18 years.
• Both sexes.
• Diagnosed with moderate to severe dry eye syndrome (DES) refractory to artificial tears.

You may not qualify if…

• Active ocular infection.
• Recent ocular surgery.
• Systemic immunosuppressive therapy.
• History of allergy to blood-derived products.

Where it is running

• The General Authority for Teaching Hospitals and Institutes — Cairo, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.